Kaven Hosseinzadeh

Kaven Hosseinzadeh practices at Loma Linda University Medical Center - Murrieta in Murrieta, California, part of Seventh-day Adventist Church.

Kaven Hosseinzadeh's NPI, 1912359605, was assigned on July 6, 2016. Kaven Hosseinzadeh graduated from St. George's University School of Medicine in 2016. Kaven Hosseinzadeh's Illinois license number on file is 125069670.

Kaven Hosseinzadeh's primary practice is Loma Linda University Medical Center - Murrieta, at 28062 Baxter Road, Murrieta, CA 92563 in Riverside County. The practice phone is (951) 290-4000.

Kaven Hosseinzadeh's primary practice is Loma Linda University Medical Center - Murrieta in Murrieta, California, part of Seventh-day Adventist Church. Kaven Hosseinzadeh is also affiliated with Southwest Healthcare Rancho Springs Hospital. The medical group on file is Vituity. Dmand AI also links Kaven Hosseinzadeh to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Kaven Hosseinzadeh practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Kaven Hosseinzadeh's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Kaven Hosseinzadeh is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Kaven Hosseinzadeh's licenses on file in 2 states: Illinois and California.

Dmand AI lists acute diabetes, acute respiratory failure, cardiac arrhythmia, cellulitis, circulation problems, circulatory problems in extremities, congestive heart failure and electrolyte disorders among the conditions Kaven Hosseinzadeh treats.

CMS data shows 1,126 Medicare services from Kaven Hosseinzadeh across 3 procedure codes in 2024, for 303 Medicare patients. Medicare paid $107,796 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 303 Medicare patients who saw Kaven Hosseinzadeh in 2024. The largest group is 75 to 84, with 124 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 2.17, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Kaven Hosseinzadeh's median patient age at 76, with 47% women.

In 2024, Kaven Hosseinzadeh wrote 460 Medicare Part D claims for 162 patients. 88% of them were for generic drugs. CMS names the drug for 166 of them, across 9 drugs with 11 or more claims each, at $11,966 in total drug cost. In 2023, CMS named 245 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 56 out of 100 for Kaven Hosseinzadeh for performance year 2024, reported individually. Kaven Hosseinzadeh accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 10 general payments to Kaven Hosseinzadeh from 3 drug and device companies from 2017 to 2024. Food and beverage make up the largest share, 100% of the total. Takeda Pharmaceuticals U.S.A., Inc. paid the most, $125.

Kaven Hosseinzadeh graduated from St. George's University School of Medicine in 2016.

Kaven Hosseinzadeh is in network with 6 carriers, including Blue Cross Blue Shield of Massachusetts, Blue Cross Blue Shield of Michigan and HCSC. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.